Company Page

Ginkgo Bioworks is a synthetic biology and biotechnology company that programs cells to produce bacteria with industrial applications. The company operates biofoundries that combine genetic engineering, automation, and AI to design microorganisms for agriculture, biopharma, biosecurity, and industrial biotech sectors. Ginkgo went public via SPAC merger in September 2021.

Company Founded in 2008

Healthtech & Biotech